Company Information & Drug Savings for Eli Lilly and Company Medications

Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana. The company develops breakthrough treatments in diabetes, oncology, immunology, and neuroscience. Key products include Mounjaro (tirzepatide) and Zepbound for type 2 diabetes and weight loss, Trulicity (dulaglutide) for diabetes, Verzenio (abemaciclib) for breast cancer, Taltz (ixekizumab) for psoriasis, and Emgality (galcanezumab) for migraine prevention. Lilly’s innovative research continues advancing treatments for obesity, Alzheimer’s disease, and other serious conditions.

Eli Lilly and Company

How to Contact Eli Lilly and Company

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch